Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering
- 29 January 2002
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (4) , 415-418
- https://doi.org/10.1161/hc0402.104119
Abstract
Background— Previous studies have demonstrated that experimental hypercholesterolemia leads to neovascularization in the coronary artery vasa vasorum (VV). Recent evidence suggests that HMG-CoA red...Keywords
This publication has 14 references indexed in Scilit:
- Inhibition of endothelial cell migration by cerivastatin, an HMG‐CoA reductase inhibitor: contribution to its anti‐angiogenic effectFEBS Letters, 2001
- The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nature Medicine, 2000
- Suppression of Invasion and MMP-9 Expression in NIH 3T3 and v-H-Ras 3T3 Fibroblasts by Lovastatin through Inhibition of Ras IsoprenylationOncology, 2000
- Adventitial vasa vasorum in balloon-injured coronary arteriesJournal of the American College of Cardiology, 1998
- Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthaseProceedings of the National Academy of Sciences, 1998
- Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.Journal of Clinical Investigation, 1998
- Direct vascular effects of HMG-CoA reductase inhibitorsPublished by Elsevier ,1998
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary VasomotionNew England Journal of Medicine, 1995
- Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries.Journal of Clinical Investigation, 1992